Huang Ping Jianfeng Accepts Field Verification of Harmonious Labor Relations Enterprises
Release time:
2021-12-23
News from our newspaper # February 14 , Zhou Renzhi, Director of Labor Relations Department of Guizhou Provincial People's Social Security Department, Zhang Yongwen, Vice Chairman of Qiandongnan Trade Union Party Group, and his party went to Huang Ping Jianfeng Cement Company to conduct on-the-spot inspection of "Guizhou Labor Relations Harmonious Enterprise " and held discussions with relevant personnel.
Deputy Secretary of Huang Ping Jianfeng Qian Jiang accompanied Zhou Renzhi and his party to visit Huang Ping Jianfeng's basketball court, badminton court, orchard, vegetable field, fitness facility, staff home and party building room and other places and facilities. After careful verification, Zhou Renzhi highly affirmed Huang Ping Jianfeng's investment in cultural and entertainment construction and the construction of a harmonious enterprise, and said that from the materials provided by the enterprise, such as labor security, trade union organization, safety management, moral and cultural construction, and the field visit of the factory appearance construction, it can be seen that Huang Ping Jianfeng is the benchmark enterprise in Huang Ping County, in the process of creating "harmonious labor relations enterprise " , seeking truth from facts and putting all the work in place in a down-to-earth manner, it is a qualified "harmonious labor relations enterprise " . He also hopes that Huang Ping Jianfeng will continue to work hard on the existing basis, seek more benefits for employees, seek more benefits for enterprises, and make more contributions to the high-quality development of the local economy.
Qian Jiang expressed his gratitude to the inspection team for its affirmation. At the same time, he also said that Huang Pingfeng will give full play to the role of administration and trade unions under the leadership of the party, implement the spirit of the guiding opinions of the CPC Central Committee and the State Council on building harmonious labor relations, and strive to achieve greater achievements in the new year by summing up experience and learning lessons, achieve for businesses and employees "for mutual benefit and win-win " . (Lei Jianbang)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31